pezeshkian rejects pressure
| |

Pezeshkian rejects pressure as Iran seeks path to de-escalation

Iranian President Masoud Pezeshkian has said Tehran will not surrender to external pressure or compromise its military and defensive capabilities, while stressing that Iran remains open to diplomacy if it can help protect the country’s interests.

In a televised interview marking the second anniversary of his presidency, Pezeshkian said Iran would resist any attempt to force it into submission. He maintained that Tehran had the right to preserve its defence capabilities and would not accept demands aimed at weakening its military strength.

The Iranian president described his country’s response during the latest conflict with the United States and Israel as an act of self-defence. He praised Iran’s armed forces, including the Army, Islamic Revolutionary Guard Corps and Aerospace Forces, for their performance during the fighting.

Pezeshkian also accused Washington and Tel Aviv of attempting to bring Gulf countries together against Iran. He said Tehran was working to prevent further regional divisions and maintained that Muslim countries should cooperate regardless of sectarian differences.

He rejected claims that Iran sought territorial expansion or intended to attack neighbouring states. According to Pezeshkian, Iran wanted peaceful relations with countries in the region and had no plans to seize territory or expand its borders.

The president also questioned why some regional countries allowed their territories to be used for attacks against Iran. He said Tehran did not seek confrontation with those states but would respond against locations from which it was attacked.

Meanwhile, senior US military officials are reportedly pushing for a path toward de-escalation as concerns grow over the effectiveness and sustainability of further military action against Iran.

According to a report, Chairman of the Joint Chiefs of Staff Gen Dan Caine has privately urged senior Trump administration officials to explore options for ending the conflict. The discussions reportedly involved senior figures including CIA Director John Ratcliffe, Secretary of State Marco Rubio and Vice President JD Vance.

US officials are said to believe that continued air operations alone may not be enough to force Tehran to accept Washington’s demands. There are also concerns about Iranian retaliation against US allies and regional energy infrastructure.

The report further indicated that shortages of some US weapons, including air-defence interceptors and precision munitions, could make a prolonged conflict increasingly difficult.

Despite the concerns, US officials reportedly believe American forces could still inflict significant damage on Iran if President Donald Trump orders further escalation. At the same time, Washington is examining diplomatic options that could allow Trump to present an agreement as a political achievement.

A possible agreement between Iran and Oman could provide a major breakthrough in efforts to reopen the Strait of Hormuz, according to a US official.

Washington expects Tehran and Muscat to reach an understanding that would allow commercial shipping and oil traffic to resume through the strategic waterway. The United States has indicated that it could lift its blockade of Iranian ports once commercial shipping is restored and Iran fulfils its commitments.

The Strait of Hormuz is one of the world’s most important energy routes, with a significant share of global oil supplies traditionally passing through it. Disruptions caused by the conflict have contributed to higher energy prices and increased inflationary pressure.

The latest diplomatic activity follows several previous claims that a deal over the strait was close, although Iranian officials have repeatedly denied that formal negotiations were taking place.

Regional tensions have also prompted Pakistan, Saudi Arabia and Türkiye to strengthen military cooperation through a joint defence agreement signed in Makkah.

Under the agreement, an armed attack against any one of the three countries would be treated as an attack against all three. The countries said the pact was intended to strengthen collective deterrence and protect regional security.

Türkiye stressed that the agreement was defensive and was not directed against any particular country. However, the deal comes amid heightened tensions involving Iran and growing concerns about the conflict spreading across the Gulf and wider Middle East.

Meanwhile, diplomatic efforts are continuing on the Lebanon front, where officials are discussing arrangements for monitoring the potential disarmament of Hezbollah under a US-backed framework.

Pezeshkian has also defended diplomatic engagement with Washington despite opposition from Iranian hardliners.

The Iranian president argued that dialogue could be useful if it allowed Tehran to safeguard its national interests and secure its rights.

Similar Posts

  • |

    Babar Azam returns to ICC Test top 10 after West Indies series

    DUBAI: Pakistan Test captain Babar Azam has climbed back into the ICC’s top 10 Test batting rankings after producing a series of important performances against the West Indies. Babar moved up five places to 10th in the latest rankings released on Wednesday, marking his first return to the elite group since September 2024. The rise comes as the Pakistan captain looks to rebuild his standing in Test cricket following a prolonged period outside the top 10. The 31-year-old played an important role in Pakistan’s campaign in the Caribbean, particularly during the second Test at Queen’s Park Oval. Pakistan won the match by eight wickets, securing an away Test victory after a wait of more than three years and levelling the two-match series 1-1. Babar made a significant contribution in the decisive match, scoring 88 runs in Pakistan’s first innings before finishing unbeaten on 24 during the successful chase. He had also made 23 and an unbeaten 58 in the opening Test, although Pakistan eventually suffered a 90-run defeat. His consistent performances have now been reflected in the latest rankings, providing another boost to the Pakistan captain as the team prepares for its upcoming Test assignments. Babar was not the only Pakistan batter to make substantial progress. Abdullah Shafique made one of the biggest jumps in the rankings after an outstanding return to the Test side. Playing his first Test since October 2025, Shafique struck an unbeaten 160 in the second Test. His innings helped Pakistan secure a 43-run first-innings lead and played a key role in setting up the victory. Shafique climbed an impressive 25 places to 32nd in the Test batting rankings. Pakistan also saw movement in the bowling and all-rounder rankings. Off-spinner Sajid Khan rose five places to 30th among Test bowlers after his performances in the Caribbean. He also climbed five spots to 32nd in the Test all-rounders’ rankings. At the top of the batting chart, Australia’s Travis Head retained the No. 1 position, while India’s Jasprit Bumrah remained the leading Test bowler. India’s Ravindra Jadeja continued to dominate the Test all-rounders’ rankings. Babar’s return to the top 10 gives Pakistan another reason for optimism, while Shafique’s rapid rise underlines the growing depth of the team’s batting options.

  • | |

    UK approves new drug aficamten for thousands of patients

    A major breakthrough has been announced in the United Kingdom for thousands of people living with obstructive hypertrophic cardiomyopathy (HCM), a serious heart condition that can significantly affect quality of life. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have simultaneously approved and recommended a new treatment, Aficamten, marketed under the brand name MYQORZO. The decision marks an important milestone in the treatment of obstructive HCM and is expected to benefit around 6,600 patients in England. The coordinated approval process between MHRA and NICE enabled the medicine to become available more quickly than usual, ensuring that eligible patients gain faster access to this innovative therapy. Aficamten is a once-daily oral tablet designed to treat obstructive hypertrophic cardiomyopathy by reducing the excessive contraction of the heart muscle. In people with HCM, the heart muscle becomes abnormally thick, making it harder for the heart to pump blood effectively. This can lead to symptoms such as shortness of breath, chest pain, fatigue, dizziness, fainting, and irregular heart rhythms. By limiting the heart muscle’s excessive contraction, Aficamten improves blood flow from the heart, enhances overall cardiac function, and helps relieve these debilitating symptoms. Clinical trials have shown that Aficamten significantly improves patients’ ability to perform physical activities and reduces many of the common symptoms associated with the disease. Participants experienced better exercise capacity and reported less breathlessness, fatigue, chest discomfort, dizziness, and episodes of abnormal heartbeat. These findings indicate that the medication can substantially improve the quality of life for patients living with obstructive HCM. According to medical experts, the effectiveness of Aficamten is comparable to Mavacamten, another approved treatment for the condition. However, one potential advantage of Aficamten is that patients may require fewer echocardiograms, or heart ultrasound scans, during treatment. This could reduce the need for frequent hospital visits and ongoing monitoring, making treatment more convenient for both patients and healthcare providers. NICE stated that Aficamten was recommended after a comprehensive cost-effectiveness assessment showed that it represents good value for the National Health Service (NHS). The organization also highlighted that close collaboration with the MHRA helped accelerate the review and approval process without compromising safety or effectiveness. Helen Knight, Director of Medicines Evaluation at NICE, described the approval as an important advancement in the treatment of this complex heart disease. She said the new medicine offers fresh hope to patients and expands the range of available treatment options. Julian Beach, Executive Director at the MHRA, said the joint effort between the two organizations demonstrates the importance of collaboration in ensuring that safe and effective medicines reach patients as quickly as possible. The decision has also been welcomed by Cardiomyopathy UK. Chief Executive Katharine McIntosh said the availability of Aficamten would provide patients with more effective treatment options and help improve their overall quality of life. According to NHS England, the new medicine will be available to eligible patients within 30 days of NICE issuing its final guidance. The pharmaceutical company has also agreed to provide the medicine to the NHS at a discounted price, making the treatment more affordable and accessible. The approval represents a significant step forward in the management of obstructive hypertrophic cardiomyopathy and offers renewed hope for thousands of patients across England.

  • | |

    Marc Anthony welcomes eighth child with wife Nadia Ferreira

    Latin music superstar Marc Anthony and his wife, former Miss Universe Paraguay contestant Nadia Ferreira, have officially welcomed their second child together, a baby girl named Myla, making the Grammy-winning singer a father of eight. ​The couple announced the joyous news through a joint Instagram post, sharing heartwarming photographs of their newborn alongside their three-year-old son, Marco. In their shared caption, the couple expressed their deep gratitude for the arrival of their daughter, writing: ​”What a great blessing to be able to share with you the arrival of our precious MYLA. You can’t imagine the happiness we have at home, we are over the moon.” ​Anthony, 57, and Ferreira, 27, first announced they were expecting again in January 2026 during their third wedding anniversary celebration. They later confirmed in March that they were expecting a girl by sharing a photo featuring tiny pink baby shoes. ​The birth of baby Myla marks another expansive chapter for Anthony’s blended family. In addition to his two children with Ferreira, the singer is father to six older children from previous relationships: daughter Arianna and son Chase with Debbie Rosado; sons Cristian and Ryan with ex-wife Dayanara Torres; and 18-year-old twins Max and Emme with ex-wife Jennifer Lopez.

  • |

    Kyiv rocked by massive Russian missile and drone assault

    More than 30 explosions shook Ukraine’s capital, Kyiv, during a fresh wave of Russian missile and drone attacks, according to Russian media reports. The strikes triggered large fires in several parts of the city, with thick smoke rising over parts of the capital as emergency crews rushed to contain the damage. Initial reports confirmed that at least one person lost their life, while five others suffered injuries. Authorities also activated air raid sirens across Kyiv and its surrounding suburbs, warning residents to seek shelter as the attacks continued. The latest assault caused significant disruption across the city and raised concerns about damage to civilian infrastructure. Emergency responders remained on the ground to extinguish fires, assist the injured, and assess the full extent of the destruction. Russian media claimed that Moscow’s forces used advanced precision-guided missiles and drones during the operation. The reports also stated that Ukraine’s air defense systems failed to intercept several of the incoming weapons, allowing multiple strikes to reach their intended targets. Ukrainian authorities have not immediately commented on those claims. The attack marks another escalation in the ongoing conflict, as both sides continue to exchange long-range strikes while fighting persists on several fronts.

  • | |

    Iqbal Chair at Heidelberg University nears restora…

    HEIDELBERG: Pakistan’s Ambassador to Germany, Saqlain Syedah, has announced that the restoration of the Allama Iqbal Chair at Heidelberg University is in its final stages, describing it as a major step towards strengthening academic and cultural ties between Pakistan and Germany. She made the announcement while addressing a literary gathering and mushaira held at Iqbal-Ufer, located on the banks of the River Neckar in the historic German city of Heidelberg. The event brought together members of the Pakistani community, writers, poets, academics and representatives of local organisations. The ceremony was chaired by renowned poet and community leader Syed Iqbal Haider, while Pakistan’s ambassador attended as the chief guest. Among the distinguished participants were Heidelberg City Council member Waseem Butt and German professor Hans Herder, whose speech in Urdu received warm appreciation from the audience. Speaking at the event, Waseem Butt announced that Allama Iqbal’s 150th birth anniversary in 2027 would be celebrated in Heidelberg with special ceremonies and cultural events. In her address, Ambassador Saqlain Syedah highlighted the importance of literary gatherings in promoting the Urdu language and preserving Pakistan’s cultural heritage abroad. She also spoke about the deep historical and intellectual connection between Allama Muhammad Iqbal and the city of Heidelberg, where the philosopher-poet spent part of his academic life. The ambassador praised Syed Iqbal Haider for organising the literary event and thanked all participants for keeping Urdu literature and Pakistani cultural traditions alive in Germany. Syed Iqbal Haider also reflected on Allama Iqbal’s close association with Heidelberg and the River Neckar. He said Iqbal’s message of selfhood, human dignity and intellectual awakening continues to serve as a bridge between Eastern and Western thought. During the ceremony, the ambassador shared the encouraging news that practical steps to restore the Allama Iqbal Chair at Heidelberg University had reached their final phase. She expressed hope that the initiative would further enhance educational cooperation and cultural exchanges between Pakistan and Germany.

Leave a Reply

Your email address will not be published. Required fields are marked *